Why are families choosing the sogroya^® pen?

It’s designed with your lifestyle in mind.

Portable

Stable at room temperature (up to 77 °F) for up to 3 days (72 hours).^a

Ready to go

Prefilled—no cartridges and no reconstitution of the medicine is required.

Easy to use

The Sogroya^® pen was rated easy or very easy to use by 99% of participants in a study.^b It’s based on the FlexPro^® you know with more than 15 years of patient experience.

Jump to device attribute chart

^aThe pen should be refrigerated (36 °F-46 °F). The pen can be taken in and out of a refrigerator as needed. The pen must be discarded 6 weeks after first use, or if it has been frozen, or in temperatures warmer than 86 °F. Keep Sogroya^® away from direct heat and light.
^bIn a randomized, crossover device preference and handling study of the Sogroya^® pen in 33 adolescents aged 10-17 with growth-related disorders and 37 caregivers aged 18 and older, 99% (69) of participants found the Sogroya^® pen easy or very easy to use. After training, users performed simulated injections into a pad or mannequin and then completed the Device Handling and Preference Assessment Questionnaire (DHPAQ).

The preferred device

In a device preference and handling study, the Sogroya^® pen was preferred by most adolescents and caregivers of children with growth-related disorders over the Ngenla™ pen and Skytrofa^® auto-injector.^a

Sogroya^® pen &
Skytrofa^® auto-injector

Sogroya^® pen &
Ngenla™ pen

In a device handling study, patients rated the Sogroya^® pen and the Skytrofa^® auto-injector:

Preferred the Sogroya^® pen over the Skytrofa^® auto-injector

(14% preferred the Skytrofa^® auto-injector over the Sogroya^® pen; 7% reported no difference between the Skytrofa^® auto-injector and the Sogroya^® pen)

Study Design

These results are drawn from a study comparing the handling of Sogroya^® pen vs Skytrofa^® auto-injector in 70 participants who had never used either or similar devices: 35 adolescents with growth-related disorders aged 10 to 17 years, and 35 caregivers 18 years of age or older.

The primary objective of the study was to evaluate patient device preference as measured by a questionnaire. Another objective was to compare the ease of use. Other events or outcomes measured in the study included device training time, preparation and injection time, and overall number of complete injections. After receiving training for both devices included in the study, participants performed a simulated injection into a pad or mannequin and completed the questionnaire.

Limitations: This study utilized a US-only, small sample size participant pool of 2 distinct groups, potentially reducing statistical power (chance of bias). Adolescents were not required to be injection naïve and children under 10 years were excluded. Assessment of treatment adherence or adverse events was not done. Each study took place in a controlled setting with assessment at a single time point, not reflecting long-term use.

In the same study:

said the Sogroya^® pen was easy or very easy to use

(57% considered the Skytrofa^® auto-injector easy or very easy to use)

said the Sogroya^® pen was faster or much faster to prepare and inject than the Skytrofa^® auto-injector

(7% rated the Skytrofa^® auto-injector faster or much faster to prepare and inject; 1% reported no difference between devices)
Average time to complete injection was 55 seconds for Sogroya^® vs 10 minutes and 37 seconds for Skytrofa^®

found the Sogroya^® pen easier or much easier to bring with you when you are outside the home than the Skytrofa^® auto-injector

(11% rated the Skytrofa^® auto-injector easier or much easier to bring with you; 19% reported no difference between devices)

These data do not establish clinical comparability of the products for any indications and should not be seen as making any claim regarding efficacy and safety. These data make no representation or conclusion as to the factors contributing to patient preference. All percentages have been rounded to the nearest whole number.

In a device handling study, patients rated the Sogroya^® and Ngenla™ pens:

preferred the Sogroya^® pen over the Ngenla™ pen

(13% preferred the Ngenla™ pen over the Sogroya^® pen; 3% reported no differences between the Ngenla™ pen and the Sogroya^® pen)

Study Design

These results are drawn from a study that compared the handling of Sogroya^® pen vs Ngenla™ pen in 70 participants who had never used either or similar devices: 33 adolescents with growth-related disorders aged 10 to 17 years, and 37 caregivers 18 years of age or older.

The primary objective was to evaluate patient device preference as measured by a questionnaire. Another objective was to compare the ease of use. Other events or outcomes measured included device training time, preparation and injection time, and overall number of complete injections. After receiving training, participants performed a simulated injection into a pad or mannequin and completed the questionnaire.

Limitations: This study utilized a US-only, small sample size participant pool of 2 distinct groups, potentially reducing statistical power (chance of bias). Adolescents were not required to be injection naïve and children under 10 years were excluded. Assessment of treatment adherence or adverse events was not done. The study took place in a controlled setting with assessment at a single time point, not reflecting long-term use.

In the same study:

said the Sogroya^® pen was easy or very easy to use

(74% considered the Ngenla™ pen easy or very easy to use)

said the Sogroya^® pen was easier or much easier to use than Ngenla™ pen

(6% considered Ngenla™ pen easier to use; 16% reported no difference between devices)

What makes the Sogroya^® pen different?

Use our tool to learn about selected attributes of the Sogroya^® pen injector and a range of other daily and weekly growth hormone therapy devices.

This chart is not intended to be a comparison of efficacy or safety of any of these products.

This is neither a comprehensive description of each product nor a complete list of available therapies. Only select attributes of select devices are shown.

Please refer to each product's full prescribing information including instructions for use.

Please refer to the complete Prescribing Information for Sogroya^® before use.

Please refer to the complete Prescribing Information for Norditropin^® before use.

Sogroya^® pen dosage strengths

Patients taking Sogroya^® will have the same starting dose whether they’re new to growth hormone treatment or are switching from a daily growth hormone therapy.

Sogroya^® is available in three dosage strengths. Your doctor will specify the pen that is right for you or your child.

NovoFine^® needles

The Sogroya^® pen is compatible with NovoFine^® needles—designed to minimize pain.^c

^cNeedles are sold separately and may require a prescription.

You pick the day

Once-weekly Sogroya^® allows you to pick the day for your weekly scheduled dose.

Friday selected for illustrative purposes only.

Not a fan of needles? PenMate^® keeps needles out of sight

Now approved for Sogroya^®, PenMate^® is a reusable cover for the Sogroya^® 5 mg, 10 mg, and 15 mg pens. Once attached to the end of a pen, it completely covers the needle, keeping it unseen as it enters the skin.

You can order your PenMate^® by contacting your NovoCare^® Case Manager or by calling 1-888-668-6444.

How to use Sogroya^® for children

Our easy-to-follow guide and videos can help your child get used to the routine.

Find out more

Actor portrayal

How to use Sogroya^® for adults

Find out how to take Sogroya^® with our helpful tools.

Actor portrayal

Show more Show less

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
are taking replacement therapy with glucocorticoids
have had cancer or any tumor
have thyroid gland problems
have diabetes
have liver problems
have adrenal gland problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya^® may affect the way some medicines work, and some medicines may affect how Sogroya^® works.

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

The most common side effects of Sogroya^® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Important Safety Information:

Do not use Norditropin^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stop breathing during sleep)
you have cancer or other tumors
you are allergic to somatropin or any of the ingredients in Norditropin^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
you are a child with closed bone growth plates (epiphyses)

Before taking Norditropin^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
have had a history of problems breathing while you sleep (sleep apnea)
have or have had cancer or any tumor
have diabetes
are pregnant or breastfeeding, or plan to become pregnant or breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin^® may affect how other medicines work, and other medicines may affect how Norditropin^® works.

How should I use Norditropin^®?

Use Norditropin^® exactly as your health care provider tells you to.
Do not share your Norditropin^® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

What are the possible side effects of Norditropin^®?

Norditropin^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin
new or worsening high blood sugar (hyperglycemia) or diabetes
increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating
your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to a lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
worsening of curvature of the spine (scoliosis)
severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you inject
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood

The most common side effects of Norditropin^® include:

injection site reactions and rashes, and headaches

Please click here for Norditropin^® Prescribing Information.

Norditropin^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

Show more Show less

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
are taking replacement therapy with glucocorticoids
have had cancer or any tumor
have thyroid gland problems
have diabetes
have liver problems
have adrenal gland problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
are taking replacement therapy with glucocorticoids
have had cancer or any tumor
have thyroid gland problems
have diabetes
have liver problems
have adrenal gland problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

Important Safety Information:

Do not use Norditropin^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stop breathing during sleep)
you have cancer or other tumors
you are allergic to somatropin or any of the ingredients in Norditropin^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
you are a child with closed bone growth plates (epiphyses)

Before taking Norditropin^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
have had a history of problems breathing while you sleep (sleep apnea)
have or have had cancer or any tumor
have diabetes
are pregnant or breastfeeding, or plan to become pregnant or breastfeed

How should I use Norditropin^®?

Use Norditropin^® exactly as your health care provider tells you to.
Do not share your Norditropin^® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

Important Safety Information:

Do not use Norditropin^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stop breathing during sleep)
you have cancer or other tumors
you are allergic to somatropin or any of the ingredients in Norditropin^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
you are a child with closed bone growth plates (epiphyses)

Before taking Norditropin^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
have had a history of problems breathing while you sleep (sleep apnea)
have or have had cancer or any tumor
have diabetes
are pregnant or breastfeeding, or plan to become pregnant or breastfeed

How should I use Norditropin^®?

Use Norditropin^® exactly as your health care provider tells you to.
Do not share your Norditropin^® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

What are the possible side effects of Norditropin^®?

Norditropin^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin
new or worsening high blood sugar (hyperglycemia) or diabetes
increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating
your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to a lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
worsening of curvature of the spine (scoliosis)
severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you inject
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood

The most common side effects of Norditropin^® include:

injection site reactions and rashes, and headaches

Please click here for Norditropin^® Prescribing Information.

Norditropin^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
are taking replacement therapy with glucocorticoids
have had cancer or any tumor
have thyroid gland problems
have diabetes
have liver problems
have adrenal gland problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Important Safety Information:

Do not use Norditropin^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stop breathing during sleep)
you have cancer or other tumors
you are allergic to somatropin or any of the ingredients in Norditropin^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
you are a child with closed bone growth plates (epiphyses)

Before taking Norditropin^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
have had a history of problems breathing while you sleep (sleep apnea)
have or have had cancer or any tumor
have diabetes
are pregnant or breastfeeding, or plan to become pregnant or breastfeed

How should I use Norditropin^®?

Use Norditropin^® exactly as your health care provider tells you to.
Do not share your Norditropin^® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

What are the possible side effects of Norditropin^®?

Norditropin^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin
new or worsening high blood sugar (hyperglycemia) or diabetes
increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating
your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels
hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to a lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
worsening of curvature of the spine (scoliosis)
severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you inject
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood

The most common side effects of Norditropin^® include:

injection site reactions and rashes, and headaches

Please click here for Norditropin^® Prescribing Information.

Norditropin^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

What is Norditropin^®?

Norditropin^® (somatropin) injection 5 mg, 10 mg, 15 mg, or 30 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

Norditropin^® is given under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone
children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
children who have Idiopathic Short Stature (ISS)
children who are not growing who have Prader-Willi syndrome (PWS)
adults who do not make enough growth hormone

Why are families choosing the sogroya® pen?

What makes the Sogroya® pen different?

Sogroya® pen dosage strengths

NovoFine® needles

You pick the day

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

What is Sogroya®?

What is Sogroya®?

Important Safety Information:

How should I use Norditropin®?

What are the possible side effects of Norditropin®?

What is Norditropin®?

What is Norditropin®?

What is Sogroya®?

What is Sogroya®?

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

What is Norditropin®?

What is Norditropin®?

Important Safety Information:

How should I use Norditropin®?

Important Safety Information:

How should I use Norditropin®?

What are the possible side effects of Norditropin®?

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

What is Sogroya®?

What is Sogroya®?

Important Safety Information:

How should I use Norditropin®?

What are the possible side effects of Norditropin®?

What is Norditropin®?

What is Norditropin®?

Why are families choosing the sogroya^® pen?

What makes the Sogroya^® pen different?

Sogroya^® pen dosage strengths

NovoFine^® needles

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

What is Sogroya^®?

What is Sogroya^®?

How should I use Norditropin^®?

What are the possible side effects of Norditropin^®?

What is Norditropin^®?

What is Norditropin^®?

What is Sogroya^®?

What is Sogroya^®?

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

What is Norditropin^®?

What is Norditropin^®?

How should I use Norditropin^®?

How should I use Norditropin^®?

What are the possible side effects of Norditropin^®?

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

What is Sogroya^®?

What is Sogroya^®?

How should I use Norditropin^®?

What are the possible side effects of Norditropin^®?

What is Norditropin^®?

What is Norditropin^®?